Moderna Inc (MRNA)

03:05 AM

Key facts: French study confirms Moderna vaccine reduces COVID-19 deaths; Moderna to present at J.P. Morgan Healthcare Conference - TradingView — Track All Markets

03:05 AM

01:35 AM

Moderna (MRNA) Stock Trades Up, Here Is Why - Finviz

01:35 AM

01:13 AM

Moderna (NASDAQ:MRNA) Trading 5.3% HigherShould You Buy? - MarketBeat

01:13 AM

10:18 AM

Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus

10:18 AM

10:00 AM

Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations - GlobeNewswire Inc.

10:00 AM

07:09 AM

Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference - Fresno Bee

07:09 AM

Dec 16, 2025

CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike - Yahoo Finance

Dec 16, 2025

Dec 16, 2025

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma - Erie Times-News

Dec 16, 2025

Dec 16, 2025

Moderna (MRNA) Is Up 5.9% After EMA Backs New mNEXSPIKE VaccineHas The Bull Case Changed? - Yahoo Finance

Dec 16, 2025

Dec 15, 2025

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) - Coshocton Tribune

Dec 15, 2025

Dec 15, 2025

FDA Commissioner Makary says 'black box' warning not coming to COVID vaccines - Seeking Alpha

Dec 15, 2025

Dec 15, 2025

Moderna Options Trading: A Deep Dive into Market Sentiment - Benzinga

Dec 15, 2025

Dec 15, 2025

Moderna (MRNA) Sees Mild Bearish Sentiment Among Option Traders - GuruFocus

Dec 15, 2025

Dec 15, 2025

Insider Selling: Moderna (NASDAQ:MRNA) Director Sells 23,853 Shares of Stock - MarketBeat

Dec 15, 2025

Dec 15, 2025

Noubar Afeyan, Moderna director, sells $703k in MRNA stock - Investing.com

Dec 15, 2025

Dec 15, 2025

Chmn Afeyan Sells 23,853 ($703.3K) Of Moderna Inc [MRNA] - TradingView — Track All Markets

Dec 15, 2025

Dec 15, 2025

Moderna’s new COVID vaccine receives positive CHMP opinion By Investing.com - Investing.com India

Dec 15, 2025

Dec 15, 2025

Moderna (MRNA) Gains European Approval Nod for New COVID Vaccine - GuruFocus

Dec 15, 2025

Dec 15, 2025

Moderna’s new COVID vaccine receives positive CHMP opinion - Investing.com

Dec 15, 2025

Dec 15, 2025

Moderna (NASDAQ: MRNA) COVID shot mNEXSPIKE backed by EMA panel for EU nod - Stock Titan

Dec 15, 2025

Dec 15, 2025

Big COVID-19 Vaccine Update: Pfizer, Moderna Nearing Finish Line - cbn.com

Dec 15, 2025

Dec 14, 2025

Moderna on track to extend gains for the seventh straight trading day - MSN

Dec 14, 2025

Dec 13, 2025

Telemark Asset Management, LLC's Moderna Inc(MRNA) Holding History - GuruFocus

Dec 13, 2025

Dec 13, 2025

Moderna to Host Investor Event – Analyst Day - York Dispatch

Dec 13, 2025

Dec 13, 2025

Bellevue Group AG Has $34.18 Million Stock Position in Moderna, Inc. $MRNA - MarketBeat

Dec 13, 2025

Dec 13, 2025

Banque Transatlantique SA Cuts Position in Moderna, Inc. $MRNA - MarketBeat

Dec 13, 2025

Dec 13, 2025

PayPal, SoundHound, Moderna, Devon, Bristol-Myers: Trending by Analysts - TipRanks

Dec 13, 2025

Dec 12, 2025

Jefferies Initiates Coverage of Moderna (MRNA) with Hold Recommendation - Nasdaq

Dec 12, 2025

Dec 12, 2025

Moderna (NASDAQ:MRNA) Director Sells $13,910.40 in Stock - MarketBeat

Dec 12, 2025

Dec 12, 2025

Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says - proactiveinvestors.com

Dec 12, 2025

Dec 12, 2025

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance - Morningstar

Dec 12, 2025

Dec 12, 2025

ImmunityBio, Moderna among winners of EU drug recommendations this week - Seeking Alpha

Dec 12, 2025

Dec 12, 2025

EMA's CHMP Recommended Granting Marketing Authorisation For Moderna's Mnexspike - TradingView

Dec 12, 2025

Dec 12, 2025

Moderna (MRNA) Faces Rising Short Interest Amid Sector Challenges - GuruFocus

Dec 12, 2025

Dec 12, 2025

Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating - marketscreener.com

Dec 12, 2025

Dec 12, 2025

MRNA: Jefferies Initiates Coverage with Hold Rating and $30 PT | - GuruFocus

Dec 12, 2025

Dec 12, 2025

Jefferies Initiates Coverage on Moderna With Hold Rating, $30 Price Target - marketscreener.com

Dec 12, 2025

Dec 12, 2025

Moderna signs deal worth up to $503m with Nanexa - Pharmaceutical Technology

Dec 12, 2025

Dec 12, 2025

Emergers: Equity Research | NANEXA: First license with Moderna an important validation of PharmaShell - TradingView — Track All Markets

Dec 12, 2025

Dec 12, 2025

Jefferies initiates Moderna stock with Hold rating, $30 price target - Investing.com

Dec 12, 2025

Dec 11, 2025

Moderna Stock On Fire: Up 23% With 7-Day Winning Streak - Trefis

Dec 11, 2025

Dec 11, 2025

Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? - Stocktwits

Dec 11, 2025

Dec 11, 2025

Petition claims FDA oops! means COVID-19 vaccines misbranded - BioWorld MedTech

Dec 11, 2025

Dec 11, 2025

Moderna protects you from illness and poor vaccine information - WSBT

Dec 11, 2025

Dec 11, 2025

Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? - GuruFocus

Dec 11, 2025

Dec 11, 2025

Moderna (MRNA) Q1 2025 Earnings Call Transcript - The Globe and Mail

Dec 11, 2025

Dec 11, 2025

Covid Shots Slash ER Visits for Kids in CDC Study - Bloomberg.com

Dec 11, 2025

Dec 11, 2025

Is the Market Bullish or Bearish on Moderna Inc? - Benzinga

Dec 11, 2025

Dec 11, 2025

Moderna and Super Micro top S&P 500 short interest list — are they ripe for a squeeze? - MSN

Dec 11, 2025

Dec 11, 2025

Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update - Finviz

Dec 11, 2025

Dec 11, 2025

US in "big danger" of falling behind in vaccine tech amid funding cuts, skepticism: Moderna co-founder - Seeking Alpha

Dec 11, 2025